NIH consensus task force report on cutaneous chronic GVHD proposes refining the 2014 skin response criteria: separate BSA scoring for epidermal and sclerotic disease, revised sclerosis descriptors, and two new clinician scales (sclerosis quality 0–10; daily function impact 0–4).
Guideline
Markova et al. Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force